NCT01012362: Study of Pazopanib and Ixabepilone in Patients With Solid Tumors |
|
|
| Terminated | 1 | 31 | US | Pazopanib, Pazopanib hydrochloride, GW786034B, Ixabepilone, IXEMPRA(TM) | Masonic Cancer Center, University of Minnesota, GlaxoSmithKline | Breast Cancer, Lung Cancer, Colon Cancer, Pancreatic Cancer, Head and Neck Cancer, Kidney Cancer, Sarcoma, Hepatocellular Cancer | 02/13 | 02/13 | | |
